[Lupus nephropathy: Insight in new treatments]

Nephrol Ther. 2018 Feb;14(1):1-12. doi: 10.1016/j.nephro.2017.05.002. Epub 2017 Nov 27.
[Article in French]

Abstract

Systemic lupus erythematosus is a chronic autoimmune disease. Both acquired and innate immune systems are involved in the development of this systemic disease. Lupus nephritis usually is the most serious manifestation of systemic lupus erythematosus, with significant morbidity and mortality. The physiopathological development of the renal involvement of lupus has been increasingly elucidated over the years and various target therapies have recently been developed. After some physiopathological reminders, we discuss the conventional treatment of lupus nephritis as well as the various therapeutic advances, in particular the contribution and the place of the new target therapies in the treatment of the lupus nephritis.

Keywords: Lupus nephropathy; Néphropathie lupique; Pathophysiology; Physiopathologie; Target therapies; Thérapies ciblées.

Publication types

  • Review

MeSH terms

  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Kidney / pathology
  • Lupus Nephritis / drug therapy*
  • Lupus Nephritis / physiopathology
  • Male
  • Molecular Targeted Therapy / methods

Substances

  • Immunosuppressive Agents